Norges Bank’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Norges Bank’s Portfolio KDNY Stock Details KDNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-28,013	Closed	-$557K	–	2141
2019 Q1	$557K	Hold	28,013	–	–	﹤0.01%	2076
2018 Q4	$370K	Sell	28,013 -29,282	-51%	-$585K	﹤0.01%	2084
2018 Q3	$2.11M	Hold	57,295	–	–	﹤0.01%	2040
2018 Q2	$2M	Hold	57,295	–	–	﹤0.01%	2025
2018 Q1	$2.66M	Hold	57,295	–	–	﹤0.01%	1975
2017 Q4	$2.15M	Hold	57,295	–	–	﹤0.01%	1968
2017 Q3	$3.05M	Hold	57,295	–	–	﹤0.01%	1930
2017 Q2	$3.27M	Hold	57,295	–	–	﹤0.01%	1943
2017 Q1	$3.08M	Hold	57,295	–	–	﹤0.01%	1958
2016 Q4	$3.27M	Buy	57,295 +15,460	+37%	+$935K	﹤0.01%	1923
2016 Q3	$2.48M	Hold	41,835	–	–	﹤0.01%	1961
2016 Q2	$2.37M	Buy	+41,835	New	+$2.54M	﹤0.01%	1987

Other funds holding KDNY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Norges Bank's KDNY Position: Q2 2019 in Review

Norges Bank sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q2 2019, closing a stake of 28,013 shares — an estimated $557K sold.

Norges Bank first reported a position in KDNY in Q2 2016 and held it in 12 quarters. The position peaked at $3.27M in Q2 2017. 97 funds tracked by Wall St. Rank hold KDNY as of Q2 2019.

Norges Bank reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
Norges Bank sold 28,013 Chinook Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $557K.
Norges Bank first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2016 and held it in 12 quarters.
Norges Bank's Chinook Therapeutics, Inc. Common Stock position peaked at $3.27M in Q2 2017.
97 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q2 2019.

Based on Norges Bank's 13F filing for Q2 2019, filed 9 Aug 2019.